Silo Pharma
SILO
14 hedge funds and large institutions have $380K invested in Silo Pharma in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0.08% less ownership
Funds ownership: 0.61% → 0.53% (-0.08%)
7% less funds holding
Funds holding: 15 → 14 (-1)
8% less capital invested
Capital invested by funds: $412K → $380K (-$32.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$30K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$22.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.39K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$113K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$13.7K |
| 3 |
VF
Virtu Financial
New York
|
-$6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.05K |
| 5 |
Citigroup
New York
|
-$1.19K |
SILO Hedge Fund Activity: Q1 2026 in Review
14 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q1 2026, worth a combined $380K — down 7.9% from $412K a quarter earlier.
Fund positioning in SILO was balanced in Q1 2026: 6 funds opened new positions, 6 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $30K. The largest seller was DRW Securities, exiting entirely with an estimated $113K sold.
- 14 institutional investors held Silo Pharma (SILO) as of Q1 2026, down from 15 in Q4 2025.
- Funds reported $380K of Silo Pharma stock for Q1 2026, down 7.9% quarter-over-quarter.
- 6 funds opened new Silo Pharma positions in Q1 2026 and 6 closed out, a net change of 0 holders.
- The largest Silo Pharma buyer in Q1 2026 was Geode Capital Management, an estimated $30K added.
- The largest Silo Pharma seller in Q1 2026 was DRW Securities, an estimated $113K sold.
Based on aggregated 13F filings for Q1 2026.